Table 2

Cancer mortality by job and exposure duration, International Agency for Research on Cancer cohort of reinforced plastics workers exposed to styrene, 1945–1991

Cancer (number of deaths)Unexposed jobs*Exposed jobsLaminatorsExposed
<2years
Exposed 2<5 yearsExposed≥5 yearsP-trend†
NRRNRR‡95% CI‡NRR95% CINRRNRR95% CINRR95% CI
NHL (29)§51.00221.010.37 to 2.7460.980.40 to 2.42171.0051.400.51 to 3.7950.920.34 to 2.540.78
Multiple myeloma (8)21.0081.050.20 to 5.370071.000.770.20 to 3.0010.23
Myeloid leukaema (15)**21.00120.570.09 to 3.4910.190.01 to 3.49101.000.530.14 to 1.9430.53
Lung (231)481.001590.850.57 to 1.19490.880.62 to 1.251441.00260.940.62 to 1.42421.140.80 to 1.620.43
Oesophagus (16)11.00153.500.46 to 26.8272.711.00 to 7.3781.001.800.62 to 5.2240.20
Pancreas (35)71.00271.060.46 to 2.4681.180.53 to 2.61191.0082.120.93 to 4.3871.330.56 to 3.190.65
Bladder (25)31.00210.920.22 to 3.8030.880.22 to 3.50181.0030.720.21 to 2.4630.540.15 to 1.940.57
Kidney (13)21.0090.830.18 to 3.9930.880.21 to 3.7171.001.080.31 to 3.7820.90
Prostate (33)51.00271.850.64 to 5.3651.360.47 to 3.89221.0040.920.32 to 2.7071.350.57 to 3.160.77
  • *Missing and unknown jobs excluded.

  • †P for continuous linear variable.

  • ‡RRs adjusted as follows: NHL, lung cancer, bladder cancer: age, calendar decade, country, sex; multiple myeloma: age, calendar decade, sex; myeloid leukaemia: age, sex, country; kidney cancer: age, calendar decade, sex; prostate cancer: age, country; pancreatic cancer, oesophageal cancer: age.

  • §Includes multiple myeloma.

  • ¶Exposure duration ≥2 years.

  • **Includes acute and chronic myeloid leukaemia.

  • NHL, non-Hodgkin’s lymphoma; RR, rate ratio.